[Monocyte-macrophage function in multiple myeloma]. 1984

T Funato, and M Hayashi, and A Koide, and Y Hirasawa, and H Ohtani, and M Saito, and F Kuto, and H Tokuhiro

UI MeSH Term Description Entries
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D009101 Multiple Myeloma A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY. Myeloma, Plasma-Cell,Kahler Disease,Myeloma, Multiple,Myeloma-Multiple,Myelomatosis,Plasma Cell Myeloma,Cell Myeloma, Plasma,Cell Myelomas, Plasma,Disease, Kahler,Multiple Myelomas,Myeloma Multiple,Myeloma, Plasma Cell,Myeloma-Multiples,Myelomas, Multiple,Myelomas, Plasma Cell,Myelomas, Plasma-Cell,Myelomatoses,Plasma Cell Myelomas,Plasma-Cell Myeloma,Plasma-Cell Myelomas
D002633 Chemotaxis The movement of cells or organisms toward or away from a substance in response to its concentration gradient. Haptotaxis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000920 Antibody-Dependent Cell Cytotoxicity The phenomenon of antibody-mediated target cell destruction by non-sensitized effector cells. The identity of the target cell varies, but it must possess surface IMMUNOGLOBULIN G whose Fc portion is intact. The effector cell is a "killer" cell possessing Fc receptors. It may be a lymphocyte lacking conventional B- or T-cell markers, or a monocyte, macrophage, or polynuclear leukocyte, depending on the identity of the target cell. The reaction is complement-independent. ADCC,Cytotoxicity, Antibody-Dependent Cell,Cell Cytoxicity, Antibody-Dependent,Antibody Dependent Cell Cytotoxicity,Antibody-Dependent Cell Cytotoxicities,Antibody-Dependent Cell Cytoxicities,Antibody-Dependent Cell Cytoxicity,Cell Cytotoxicities, Antibody-Dependent,Cell Cytotoxicity, Antibody-Dependent,Cell Cytoxicities, Antibody-Dependent,Cell Cytoxicity, Antibody Dependent,Cytotoxicities, Antibody-Dependent Cell,Cytotoxicity, Antibody Dependent Cell,Cytoxicities, Antibody-Dependent Cell,Cytoxicity, Antibody-Dependent Cell

Related Publications

T Funato, and M Hayashi, and A Koide, and Y Hirasawa, and H Ohtani, and M Saito, and F Kuto, and H Tokuhiro
July 2014, European journal of haematology,
T Funato, and M Hayashi, and A Koide, and Y Hirasawa, and H Ohtani, and M Saito, and F Kuto, and H Tokuhiro
November 1977, American journal of diseases of children (1960),
T Funato, and M Hayashi, and A Koide, and Y Hirasawa, and H Ohtani, and M Saito, and F Kuto, and H Tokuhiro
January 1990, Contributions to nephrology,
T Funato, and M Hayashi, and A Koide, and Y Hirasawa, and H Ohtani, and M Saito, and F Kuto, and H Tokuhiro
October 2022, International journal of molecular sciences,
T Funato, and M Hayashi, and A Koide, and Y Hirasawa, and H Ohtani, and M Saito, and F Kuto, and H Tokuhiro
February 1994, Medicine and science in sports and exercise,
T Funato, and M Hayashi, and A Koide, and Y Hirasawa, and H Ohtani, and M Saito, and F Kuto, and H Tokuhiro
April 2014, Leukemia,
T Funato, and M Hayashi, and A Koide, and Y Hirasawa, and H Ohtani, and M Saito, and F Kuto, and H Tokuhiro
November 1995, Annals of neurology,
T Funato, and M Hayashi, and A Koide, and Y Hirasawa, and H Ohtani, and M Saito, and F Kuto, and H Tokuhiro
January 1984, Progress in clinical and biological research,
T Funato, and M Hayashi, and A Koide, and Y Hirasawa, and H Ohtani, and M Saito, and F Kuto, and H Tokuhiro
July 2013, International journal of molecular sciences,
T Funato, and M Hayashi, and A Koide, and Y Hirasawa, and H Ohtani, and M Saito, and F Kuto, and H Tokuhiro
January 1984, Contributions to nephrology,
Copied contents to your clipboard!